EUVIMEDEUVIMED entdecken
Crossref

Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors

Kunal Nandy, Shraddha Patkar, Subhash Yadav, Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargav, Mahesh Goel

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Kunal Nandy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Division of Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Neuroendocrine neoplasms (NENs) are classified as neuroendocrine tumors (NETs), neuroendocrine carcinomas (NECs), and mixed neuroendocrine and nonneuroendocrine neoplasms (MiNENs) according to World Health Organization classification. We present our experience of NENs of the gallbladder (GB) from a high‐volume cancer hospital. Materials and Methods The present study is a retrospective analysis of all patients with GB NENs who presented between January 2015 and June 2023. The patient details and treatment received with follow‐up were noted. The primary endpoint was overall survival (OS).

Results

A total of 147 patients were included in the study. The median age was 52 (27–81) years. There was a female predominance (70.7%). NEC was the most common subtype (84.4%) followed by MiNEN (12.9%) and NET (2.7%). The most common stage at presentation was metastatic (70.7%) followed by locally advanced (21.8%), and early disease (7.5%). The median follow‐up was 9.92 (1.77–76.06) months. Median OS was 6.14 (3.93–8.35) months. Median OS in patients who received multimodality treatment was 20.20 (17.99–22.41) months versus 4.00 (2.91–5.10) months in those who did not receive it.

Conclusion

GB NENs are rare, but aggressive tumors with NEC being the most common type. Multimodality treatment yields favorable outcomes. However, the development of better systemic therapy is needed to help improve survival further.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallbladder NeoplasmsNeuroendocrine TumorsHumansFemaleMaleMiddle AgedAgedRetrospective StudiesAdultAged, 80 and overPrognosisSurvival RateFollow-Up StudiesCombined Modality Therapy

Stichwörter der Autor:innen

MiNENmultimodality treatmentneuroendocrine carcinomaneuroendocrine neoplasmsneuroendocrine tumor

Autor:innen und Institutionen

  • Hepatobiliary Division of Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
  • Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
  • Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.

Zitieren

APA

Nandy, K., Patkar, S., Yadav, S., Ostwal, V., Ramaswamy, A., Bhargav, P., & Goel, M. (2024). Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27600

Vancouver

Nandy K, Patkar S, Yadav S, Ostwal V, Ramaswamy A, Bhargav P, et al. Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27600

BibTeX
@article{Nandy2024,
  author = {Nandy, Kunal and Patkar, Shraddha and Yadav, Subhash and Ostwal, Vikas and Ramaswamy, Anant and Bhargav, Prabhat and Goel, Mahesh},
  title = {Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27600}
}
Kostenlos starten →